KINGSLEY ALFRED D

CIK 00012293393 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001229339

Recent Transactions

50 trades

Award
Lineage Cell Therapeutics, Inc.$LCTX
Stock Option (Right to Buy)
2023-07-01+50,000→ 50,000 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Option to Purchase Common Stock
2023-06-23+90,000→ 90,000 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2023-06-23+20,000→ 489,111 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2023-06-14$0.21/sh+30,000→ 469,111 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2022-12-22$0.28/sh+25,000→ 439,111 total
Gift
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2022-12-01−25,000→ 5,430,545 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2022-08-15+10,000→ 404,111 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Option to Purchase Common Stock
2022-08-15+45,000→ 45,000 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2022-08-15$0.97/sh+5,000→ 409,111 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2022-08-15$0.97/sh+5,000→ 414,111 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Stock Option (right to buy)
2022-07-01+50,000→ 50,000 total
Exercise/Conversion
Insight Molecular Diagnostics Inc.$IMDX
Restricted Stock Units
2022-06-24−10,000→ 0 total
Exercise/Conversion
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2022-06-24+10,000→ 394,111 total
Gift
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2021-12-01−14,700→ 5,455,545 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Stock Option (right to buy)
2021-07-01+80,000→ 80,000 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Option to Purchase Common Stock
2021-06-24+45,000→ 45,000 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Restricted Stock Units
2021-06-24+10,000→ 10,000 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2021-06-22$2.20/sh+61,800→ 5,470,245 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Stock Option (right to buy)
2021-06-22−61,800→ 0 total
Exercise/Conversion
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2020-12-28$1.34/sh+65,271→ 384,111 total
Exercise/Conversion
Insight Molecular Diagnostics Inc.$IMDX
Option to purchase common stock
2020-12-28$1.34/sh+65,271→ 0 total
Exercise/Conversion
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2020-12-23$1.34/sh+1,237→ 319,740 total
Sale
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2020-12-23$2.55/sh−900→ 318,840 total
Exercise/Conversion
Insight Molecular Diagnostics Inc.$IMDX
Option to purchase common stock
2020-12-23$1.34/sh+1,237→ 65,271 total
Exercise/Conversion
Insight Molecular Diagnostics Inc.$IMDX
Option to purchase common stock
2020-12-22$1.34/sh+10,516→ 66,508 total
Sale
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2020-12-22−7,652→ 318,503 total
Exercise/Conversion
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2020-12-22$1.34/sh+10,516→ 326,155 total
Sale
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2020-12-21$2.54/sh−5,148→ 315,639 total
Exercise/Conversion
Insight Molecular Diagnostics Inc.$IMDX
Option to purchase common stock
2020-12-21$1.34/sh+47,976→ 77,024 total
Exercise/Conversion
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2020-12-21$1.34/sh+47,976→ 350,787 total
Sale
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2020-12-21−30,000→ 320,787 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2020-12-11+5,909→ 302,811 total
Gift
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2020-12-01−17,500→ 5,408,445 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Stock Option (Right to Buy)
2020-07-01+70,000→ 70,000 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Option to purchase common stock
2020-06-17+57,000→ 57,000 total
Gift
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2019-09-01−32,000→ 5,425,945 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Option to Purchase Common Stock
2019-07-17+45,000→ 45,000 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Stock Option (Right to Buy)
2019-07-01+70,000→ 70,000 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2019-03-08+6,390→ 5,457,945 total
Gift
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2018-11-01−20,000→ 5,451,555 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Option to Purchase Common Stock
2018-08-30+45,000→ 45,000 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Option to Purchase Common Shares
2018-07-01+70,000→ 70,000 total
Gift
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2017-12-01−100,000→ 1,043,346 total
Gift
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2017-10-01−10,000→ 5,471,555 total
Disposition to Issuer
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2017-08-17$2.81/sh−300,000→ 5,481,555 total
Sale
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2017-07-31$2.80/sh−150,000→ 5,781,555 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Option to Purchase Common Shares
2017-07-01+50,000→ 50,000 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Option to Purchase Common Stock
2017-06-15+16,300→ 16,300 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Option to Purchase Common Stock
2017-06-15+50,000→ 50,000 total
Other
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2017-01-03−238,469→ 1,143,346 total

Companies

Recent Filings

Address

150 E. 57TH STREET

NEW YORK, NY, 10022

View on SEC.gov